Search Results - "Mutlib, A"

Refine Results
  1. 1

    Late sodium current block for drug-induced long QT syndrome: Results from a prospective clinical trial by Johannesen, L, Vicente, J, Mason, JW, Erato, C, Sanabria, C, Waite-Labott, K, Hong, M, Lin, J, Guo, P, Mutlib, A, Wang, J, Crumb, WJ, Blinova, K, Chan, D, Stohlman, J, Florian, J, Ugander, M, Stockbridge, N, Strauss, DG

    Published in Clinical pharmacology and therapeutics (01-02-2016)
    “…Drug‐induced long QT syndrome has resulted in many drugs being withdrawn from the market. At the same time, the current regulatory paradigm for screening new…”
    Get full text
    Journal Article
  2. 2

    Kinetics of Acetaminophen Glucuronidation by UDP-Glucuronosyltransferases 1A1, 1A6, 1A9 and 2B15. Potential Implications in Acetaminophen−Induced Hepatotoxicity by Mutlib, Abdul E, Goosen, Theunis C, Bauman, Jonathan N, Williams, J. Andrew, Kulkarni, Shaila, Kostrubsky, Seva

    Published in Chemical research in toxicology (01-05-2006)
    “…The importance of uridine 5‘-diphosphate-glucuronosyltranferases (UGT) 2B15 and other UGT enzymes (1A1, 1A6, and 1A9) in glucuronidating acetaminophen (APAP)…”
    Get full text
    Journal Article
  3. 3

    Identification and Characterization of Efavirenz Metabolites by Liquid Chromatography/Mass Spectrometry and High Field NMR: Species Differences in the Metabolism of Efavirenz by MUTLIB, A. E, CHEN, H, NEMETH, G. A, MARKWALDER, J. A, SEITZ, S. P, GAN, L. S, CHRIST, D. D

    Published in Drug metabolism and disposition (01-11-1999)
    “…Efavirenz (Sustiva, Fig. 1 ) is a potent and specific inhibitor of HIV-1 reverse transcriptase approved for the treatment of HIV infection. To examine the…”
    Get full text
    Journal Article
  4. 4

    Application of stable isotope labeled glutathione and rapid scanning mass spectrometers in detecting and characterizing reactive metabolites by Mutlib, Abdul, Lam, Wing, Atherton, Jim, Chen, Hao, Galatsis, Paul, Stolle, Wayne

    Published in Rapid communications in mass spectrometry (01-01-2005)
    “…The formation of reactive metabolites from a number of compounds was studied in vitro using a mixture of non‐labeled and stable isotope labeled glutathione…”
    Get full text
    Journal Article
  5. 5

    Phenobarbital and Phenytoin Increased Acetaminophen Hepatotoxicity Due to Inhibition of UDP-Glucuronosyltransferases in Cultured Human Hepatocytes by Kostrubsky, Seva E., Sinclair, Jacqueline F., Strom, Stephen C., Wood, Sheryl, Urda, Ellen, Stolz, Donna Beer, Wen, Yuan H., Kulkarni, Shaila, Mutlib, Abdul

    Published in Toxicological sciences (01-09-2005)
    “…Here we present a preclinical model to assess drug–drug interactions due to inhibition of glucuronidation. Treatment with the antiepileptics phenobarbital (PB)…”
    Get full text
    Journal Article
  6. 6

    Transport, Metabolism, and Hepatotoxicity of Flutamide, Drug–Drug Interaction with Acetaminophen Involving Phase I and Phase II Metabolites by Kostrubsky, Seva E, Strom, Stephen C, Ellis, Ewa, Nelson, Sidney D, Mutlib, Abdul E

    Published in Chemical research in toxicology (01-10-2007)
    “…Treatment with flutamide has been associated with clinical hepatotoxicty. The toxicity, metabolism,and transport of flutamide were investigated using cultured…”
    Get full text
    Journal Article
  7. 7

    Pharmacological evaluation of novel Alzheimer's disease therapeutics: acetylcholinesterase inhibitors related to galanthamine by Bores, G M, Huger, F P, Petko, W, Mutlib, A E, Camacho, F, Rush, D K, Selk, D E, Wolf, V, Kosley, Jr, R W, Davis, L, Vargas, H M

    “…Acetylcholinesterase (AChE) inhibitors from several chemical classes have been tested for the symptomatic treatment of Alzheimer's disease; however, the…”
    Get more information
    Journal Article
  8. 8

    Application of hyphenated LC/NMR and LC/MS techniques in rapid identification of in vitro and in vivo metabolites of iloperidone by Mutlib, A E, Strupczewski, J T, Chesson, S M

    Published in Drug metabolism and disposition (01-09-1995)
    “…Iloperidone, 1(-)[4(-)[3(-)[4-(6-fluro-1,2-benzisoxazol-3-yl)-1- piperidinyl]propoxy]-3-methoxyphenyl]ethanone, is currently undergoing clinical trials as a…”
    Get more information
    Journal Article
  9. 9
  10. 10

    Liquid Chromatography/Mass Spectrometry and High-Field Nuclear Magnetic Resonance Characterization of Novel Mixed Diconjugates of the Non-nucleoside Human Immunodeficiency Virus-1 Reverse Transcriptase Inhibitor, Efavirenz by MUTLIB, A. E, CHEN, H, NEMETH, G, GAN, L.-S, CHRIST, D. D

    Published in Drug metabolism and disposition (01-09-1999)
    “…Efavirenz (Sustiva) is a potent and specific inhibitor of the HIV-1 reverse transcriptase and is approved for the treatment of HIV infection. The metabolism of…”
    Get full text
    Journal Article
  11. 11

    A comprehensive listing of bioactivation pathways of organic functional groups by Kalgutkar, Amit S, Gardner, Iain, Obach, R Scott, Shaffer, Christopher L, Callegari, Ernesto, Henne, Kirk R, Mutlib, Abdul E, Dalvie, Deepak K, Lee, Jae S, Nakai, Yasuhiro, O'Donnell, John P, Boer, Jason, Harriman, Shawn P

    Published in Current drug metabolism (01-06-2005)
    “…The occurrence of idiosyncratic adverse drug reactions during late clinical trials or after a drug has been released can lead to a severe restriction in its…”
    Get more information
    Journal Article
  12. 12

    Application of liquid chromatography/mass spectrometry in accelerating the identification of human liver cytochrome P450 isoforms involved in the metabolism of iloperidone by Mutlib, A E, Klein, J T

    “…Iloperidone, [1-[4-[3-[4-(6-fluoro-1, 2-benzisoxazol-3-yl)-1-piperidinyl]propoxy]-3-methoxyphenyl]eth anone, 1, is currently undergoing clinical trials as a…”
    Get more information
    Journal Article
  13. 13

    Mass spectrometric and NMR characterization of metabolites of roxifiban, a potent and selective antagonist of the platelet glycoprotein IIb/IIIa receptor by Mutlib, A. E., Diamond, S., Shockcor, J., Way, R., Nemeth, G., Gan, L., Christ, D. D.

    Published in Xenobiotica (01-11-2000)
    “…1. The methylester prodrug roxifiban is an orally active, potent and selective antagonist of the platelet glycoprotein GPIIb/IIIa receptor and is being…”
    Get full text
    Journal Article
  14. 14
  15. 15

    Simultaneous quantification of seven active metabolites of roxifiban in human plasma by LC/MS/MS in the presence of an interfering displacer at millimolar concentrations by Shi, G, Lloyd, T.L, Sy, S.K.B, Jiao, Q, Wernicki, A, Mutlib, A, Emm, T.A, Unger, S.E, Pieniaszek, H.J

    “…Roxifiban (DMP 754) is a glycoprotein (GP) IIb/IIIa antagonist. Following oral administration to humans, roxifiban is metabolized to its primary active…”
    Get full text
    Journal Article
  16. 16

    Metabolism of an atypical antipsychotic agent, 3-[4-[4-(6-fluorobenzo[b]thien-3-yl)-1-piperazinyl]butyl]-2, 5,5-trimethyl-4-thiazolidinone (HP236) by Mutlib, A E, Jurcak, J, Hrib, N

    Published in Drug metabolism and disposition (01-10-1996)
    “…Metabolism of an atypical antipsychotic agent, 3-[4-[4-(6-fluorobenzo[b]thien-3-yl)-1-piperazinyl]butyl]-2, 5,5-trimethyl-4-thiazolidinone (HP236) by rats is…”
    Get more information
    Journal Article
  17. 17
  18. 18
  19. 19

    Isolation and characterization of carbinolamide and phenolic glucuronide conjugates of (+-)-N-methyl-N-(1-methyl-3,3-diphenylpropyl) formamide and N-formylmethamphetamine by FAB/MS, LC/MS/MS, and NMR by Mutlib, A E, Abbott, F S

    Published in Drug metabolism and disposition (01-05-1992)
    “…The metabolic disposition of (+-)-N-methyl-N-(1-methyl-3,3- diphenyl-propyl)formamide, especially with regard to the formation of water soluble glucuronides,…”
    Get more information
    Journal Article
  20. 20

    Bioactivation of Benzylamine to Reactive Intermediates in Rodents:  Formation of Glutathione, Glutamate, and Peptide Conjugates by Mutlib, Abdul E, Dickenson, Patricia, Chen, Shiang-Yuan, Espina, Robert J, Daniels, J. Scott, Gan, Liang-Shang

    Published in Chemical research in toxicology (01-09-2002)
    “…The in vivo and in vitro disposition of benzylamine was investigated in rats. Benzylamine was metabolized to only a small extent by rat liver subcellular…”
    Get full text
    Journal Article